Limitations and Possibilities of Transarterial Chemotherapeutic Treatment of Hepatocellular Carcinoma

Because diagnostic tools for discriminating between hepatocellular carcinoma (HCC) and advanced cirrhosis are poor, HCC is often detected in a stage where transarterial chemoembolization (TACE) is the best treatment option, even though it provides a poor survival gain. Despite having been used world...

Descripción completa

Detalles Bibliográficos
Autores principales: Ebeling Barbier, Charlotte, Heindryckx, Femke, Lennernäs, Hans
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8658005/
https://www.ncbi.nlm.nih.gov/pubmed/34884853
http://dx.doi.org/10.3390/ijms222313051

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8658005/
https://www.ncbi.nlm.nih.gov/pubmed/34884853
http://dx.doi.org/10.3390/ijms222313051

Ejemplares similares